Timing of elective surgery and risk assessment after SARS‐CoV ‐2 infection: an update
Top Cited Papers
Open Access
- 22 February 2022
- journal article
- research article
- Published by Wiley in Anaesthesia
- Vol. 77 (5) , 580-587
Abstract
Summary: The impact of vaccination and new SARS‐CoV‐2 variants on peri‐operative outcomes is unclear. We aimed to update previously published consensus recommendations on timing of elective surgery after SARS‐CoV‐2 infection to assist policymakers, administrative staff, clinicians and patients. The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting. We recommend individualised multidisciplinary risk assessment for patients requiring elective surgery within 7 weeks of SARS‐CoV‐2 infection. This should include baseline mortality risk calculation and assessment of risk modifiers (patient factors; SARS‐CoV‐2 infection; surgical factors). Asymptomatic SARS‐CoV‐2 infection with previous variants increased peri‐operative mortality risk three‐fold throughout the 6 weeks after infection, and assumptions that asymptomatic or mildly symptomatic omicron SARS‐CoV‐2 infection does not add risk are currently unfounded. Patients with persistent symptoms and those with moderate‐to‐severe COVID‐19 may require a longer delay than 7 weeks. Elective surgery should not take place within 10 days of diagnosis of SARS‐CoV‐2 infection, predominantly because the patient may be infectious, which is a risk to surgical pathways, staff and other patients. We now emphasise that timing of surgery should include the assessment of baseline and increased risk, optimising vaccination and functional status, and shared decision‐making. While these recommendations focus on the omicron variant and current evidence, the principles may also be of relevance to future variants. As further data emerge, these recommendations may be revised.Keywords
This publication has 16 references indexed in Scilit:
- Mortality after surgery with SARS-CoV-2 infection in England: a population-wide epidemiological studyBritish Journal of Anaesthesia, 2021
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataThe Lancet, 2021
- SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort studyBritish Journal of Surgery, 2021
- SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgeryAnaesthesia, 2021
- Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort studyAnaesthesia, 2021
- Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort StudyJournal of Clinical Oncology, 2021
- Risk to health from COVID‐19 for anaesthetists and intensivists – a narrative reviewAnaesthesia, 2020
- Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort studyThe Lancet, 2020
- Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plansBritish Journal of Surgery, 2020
- COVID-19: the case for health-care worker screening to prevent hospital transmissionThe Lancet, 2020